Cargando…
The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3β in Pancreatic Cancer
Pancreatic cancer (PaCa) is the fourth leading cause of cancer-related death, and personalized targeted cancer therapy is becoming a promising treatment strategy for PaCa. The central approach of targeted therapy is to find a targetable key and an effective targeting method. In this study, the impor...
Autores principales: | Liu, Bin, Yang, Hai, Pilarsky, Christian, Weber, Georg F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073545/ https://www.ncbi.nlm.nih.gov/pubmed/29949874 http://dx.doi.org/10.3390/ijms19071870 |
Ejemplares similares
-
Addendum: Liu, B. et al. The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3β in Pancreatic Cancer. Int. J. Mol. Sci. 2018, 19, 1870
por: Liu, Bin, et al.
Publicado: (2019) -
Upregulated GPRC5A disrupting the Hippo pathway promotes the proliferation and migration of pancreatic cancer cells via the cAMP-CREB axis
por: Fang, Weidan, et al.
Publicado: (2023) -
Phosphorylation of LCRMP-1 by GSK3β Promotes Filopoda Formation, Migration and Invasion Abilities in Lung Cancer Cells
por: Wang, Wen-Lung, et al.
Publicado: (2012) -
EGFR phosphorylates and inhibits lung tumor suppressor GPRC5A in lung cancer
por: Lin, Xiaofeng, et al.
Publicado: (2014) -
Osteocalcin Promotes β-Cell Proliferation During Development and Adulthood Through Gprc6a
por: Wei, Jianwen, et al.
Publicado: (2014)